| SCQ: Social communication questionnaire M Rutter (No Title), 2003 | 604 | 2003 |
| Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy F Muntoni, M Cau, A Ganau, R Congiu, G Arvedi, A Mateddu, MG Marrosu, ... New England Journal of Medicine 329 (13), 921-925, 1993 | 573 | 1993 |
| Increased sensitivity of the neuronal nicotinic receptor α2 subunit causes familial epilepsy with nocturnal wandering and ictal fear P Aridon, C Marini, C Di Resta, E Brilli, M De Fusco, F Politi, E Parrini, ... The American Journal of Human Genetics 79 (2), 342-350, 2006 | 292 | 2006 |
| Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene MG Marrosu, S Vaccargiu, G Marrosu, A Vannelli, C Cianchetti, F Muntoni Neurology 50 (5), 1397-1401, 1998 | 211 | 1998 |
| A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. F Muntoni, L Wilson, G Marrosu, MG Marrosu, C Cianchetti, L Mestroni, ... The Journal of clinical investigation 96 (2), 693-699, 1995 | 150 | 1995 |
| Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation A ZUDDAS, A DI MARTINO, P MUGLIA, C CIANCHETTI Journal of Child and Adolescent Psychopharmacology 10 (2), 79-90, 2000 | 136 | 2000 |
| Clinical effects of clozapine on autistic disorder. A Zuddas, MG Ledda, A Fratta, P Muglia, C Cianchetti American Psychiatric Assn, 1996 | 135 | 1996 |
| The perceived burden of epilepsy: impact on the quality of life of children and adolescents and their families C Cianchetti, P Messina, E Pupillo, G Crichiutti, MG Baglietto, P Veggiotti, ... Seizure 24, 93-101, 2015 | 119 | 2015 |
| Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study A Di Martino, G Melis, C Cianchetti, A Zuddas Journal of Child and Adolescent Psychopharmacology 14 (2), 207-218, 2004 | 119 | 2004 |
| Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man GU Corsini, M DEL ZOMPO, S Manconi, C Cianchetti, A Mangoni, ... Advances in biochemical psychopharmacology 16, 645-648, 1977 | 115 | 1977 |
| SAFA: Scale psichiatriche di autosomministrazione per fanciulli e adolescenti C Cianchetti, G Sannio Fancello Organizzazioni Speciali, Firenze, 2001 | 114 | 2001 |
| Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy F Muntoni, A Di Lenarda, M Porcu, G Sinagra, A Mateddu, G Marrosu, ... Heart 78 (6), 608-612, 1997 | 108 | 1997 |
| Shoe-makers' polyneuropathy in Italy: the aetiological problem. G Abbritti, A Siracusa, C Cianchetti, A Coli, F Curradi, GF Perticoni, ... Occupational and Environmental Medicine 33 (2), 92-99, 1976 | 107 | 1976 |
| Toxic polyneuropathy of shoe-industry workers. A study of 122 cases. CF Cianchetti Carlo, Abbritti G, Perticoni G, Siracusa A J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1151-61. 39 (Dec), 1151-1161, 1976 | 107* | 1976 |
| HLA‐DQB1 genotype in Sardinian multiple sclerosis: Evidence for a key role of DQB1 *0201 and *0302 alleles MG Marrosu, F Muntoni, MR Murru, G Costa, MP Pischedda, M Pirastu, ... Neurology 42 (4), 883-883, 1992 | 92 | 1992 |
| Botulinum toxin type a as a therapeutic agent against headache and related disorders S Luvisetto, P Gazerani, C Cianchetti, F Pavone Toxins 7 (9), 3818-3844, 2015 | 91 | 2015 |
| Epileptic seizures and headache/migraine: a review of types of association and terminology C Cianchetti, D Pruna, MG Ledda Seizure 22 (9), 679-685, 2013 | 88 | 2013 |
| Test TVL. Test di valutazione del linguaggio. Livello prescolare C Cianchetti, GS Fancello Edizioni Erickson, 1997 | 86 | 1997 |
| TVL Test di valutazione del linguaggio C Cianchetti, G Sannio Fancello Erickson, Trento, 1997 | 86* | 1997 |
| Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset A Zuddas, B Ancilletta, P Muglia, C Cianchetti European Journal of Paediatric Neurology 4 (2), 53-62, 2000 | 83 | 2000 |
